122 related articles for article (PubMed ID: 31399174)
21. Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians.
Likhitsup A; Parikh ND
Pharmacoeconomics; 2020 Jan; 38(1):5-24. PubMed ID: 31573053
[TBL] [Abstract][Full Text] [Related]
22. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
23. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
[TBL] [Abstract][Full Text] [Related]
24. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
[TBL] [Abstract][Full Text] [Related]
25. Timing of Antiviral Therapy in Candidates for Liver Transplant for Hepatitis C and Hepatocellular Carcinoma.
Saab S; Jimenez M; Fong T; Wu C; El Kabany M; Tong MJ
Exp Clin Transplant; 2016 Feb; 14(1):66-71. PubMed ID: 26581477
[TBL] [Abstract][Full Text] [Related]
26. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
Groeschl RT; Turaga KK; Gamblin TC
J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
[TBL] [Abstract][Full Text] [Related]
27. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
[TBL] [Abstract][Full Text] [Related]
28. Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates.
De Simone P; Vignali C; Petruccelli S; Carrai P; Coletti L; Montin U; Catalano G; Urbani L; Filipponi F
Transplant Proc; 2006 Dec; 38(10):3561-3. PubMed ID: 17175331
[TBL] [Abstract][Full Text] [Related]
29. Health insurance status affects staging and influences treatment strategies in patients with hepatocellular carcinoma.
Zaydfudim V; Whiteside MA; Griffin MR; Feurer ID; Wright JK; Pinson CW
Ann Surg Oncol; 2010 Dec; 17(12):3104-11. PubMed ID: 20585872
[TBL] [Abstract][Full Text] [Related]
30. Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison.
Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos R; Brown RS; Ibrahim S; Fortune BE; Talenfeld AD; Madoff DC; Johnson MS; Sedrakyan A
AJR Am J Roentgenol; 2024 Jun; ():. PubMed ID: 38899842
[No Abstract] [Full Text] [Related]
31. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
Berry K; Ioannou GN
Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
[TBL] [Abstract][Full Text] [Related]
32. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function.
Benjamin AJ; Baker TB; Talamonti MS; Bodzin AS; Schneider AB; Winschester DJ; Roggin KK; Bentrem DJ; Suss NR; Baker MS
Surgery; 2018 Mar; 163(3):582-586. PubMed ID: 29370929
[TBL] [Abstract][Full Text] [Related]
33. Pricey pills for an even pricier problem.
Kwan SW
Cancer; 2016 Mar; 122(6):840-1. PubMed ID: 26716603
[No Abstract] [Full Text] [Related]
34. Liver Transplantation for High Risk Hepatocellular Carcinoma After Liver Resection: A Sequential or Salvage Approach?
Lin CC; Elsarawy AM; Li WF; Lin TL; Yong CC; Wang SH; Wang CC; Kuo FY; Cheng YF; Chen CL
Ann Transplant; 2017 Oct; 22():602-610. PubMed ID: 28993607
[TBL] [Abstract][Full Text] [Related]
35. Survival outcomes of liver transplantation versus liver resection among patients with hepatocellular carcinoma: A SEER-based longitudinal study.
Zhang K; Chen R; Gong X; Gao Y
J Formos Med Assoc; 2019 Apr; 118(4):790-796. PubMed ID: 30482570
[TBL] [Abstract][Full Text] [Related]
36. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?
Adam R; Bhangui P; Vibert E; Azoulay D; Pelletier G; Duclos-Vallée JC; Samuel D; Guettier C; Castaing D
Ann Surg; 2012 Dec; 256(6):883-91. PubMed ID: 23108125
[TBL] [Abstract][Full Text] [Related]
37. Management of the single liver nodule in a cirrhotic patient: a decision analysis model.
El-Serag HB; Mallat DB; Rabeneck L
J Clin Gastroenterol; 2005 Feb; 39(2):152-9. PubMed ID: 15681913
[TBL] [Abstract][Full Text] [Related]
38. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
39. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.
Roayaie S; Haim MB; Emre S; Fishbein TM; Sheiner PA; Miller CM; Schwartz ME
Ann Surg Oncol; 2000 Dec; 7(10):764-70. PubMed ID: 11129425
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
